Porcine deltacoronavirus accessory protein NS6 harnesses VPS35-mediated retrograde trafficking to facilitate efficient viral infection.
VPS35
accessory protein NS6
evasion
porcine deltacoronavirus
retromer
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
10 Oct 2023
10 Oct 2023
Historique:
medline:
10
10
2023
pubmed:
10
10
2023
entrez:
10
10
2023
Statut:
aheadofprint
Résumé
Porcine deltacoronavirus (PDCoV) is an emerging swine enteropathogenic coronavirus with the potential to infect humans. Accessory protein NS6, encoded by PDCoV, is a key factor required for optimal viral replication. However, the precise mechanism(s) used by PDCoV NS6 to function remains largely unclear. The retromer is an evolutionarily highly conserved protein complex that plays an important role in normal cellular biological processes and viral replication. In this study, we identified VPS35, a subunit of the retromer complex, as a potential NS6-interacting protein via immunoprecipitation and mass spectrometry analysis in the context of PDCoV infection. Furthermore, we confirmed the interaction of VPS35 with NS6 by co-immunoprecipitation in both an overexpression system and PDCoV-infected cells. Knockdown of VPS35 by specific small interfering RNA inhibited wild-type PDCoV infection but did not suppress the infection of recombinant PDCoVs with an NS6 deletion, demonstrating that the VPS35-NS6 interaction is required for the proviral function of VPS35. We further demonstrated that the lysosomal pathway and Golgi trafficking are required for efficient PDCoV infection and that depletion of VPS35 prevented retrograde transport of PDCoV NS6 from endosomes to the Golgi, resulting in its lysosomal degradation and the inhibition of viral production. Taken together, our findings are the first to identify VPS35 as a critical host factor required for PDCoV to establish productive infection, revealing a novel evasion mechanism of PDCoV.IMPORTANCERetrograde transport has been reported to be closely associated with normal cellular biological processes and viral replication. As an emerging enteropathogenic coronavirus with zoonotic potential, porcine deltacoronavirus (PDCoV) has attracted considerable attention. However, whether retrograde transport is associated with PDCoV infection remains unclear. Our present study demonstrates that retromer protein VPS35 acts as a critical host factor that is required for PDCoV infection. Mechanically, VPS35 interacts with PDCoV NS6, mediating the retrograde transport of NS6 from endosomes to the Golgi and preventing it from lysosomal degradation. Recombinant PDCoVs with an NS6 deletion display resistance to VPS35 deficiency. Our work reveals a novel evasion mechanism of PDCoV that involves the manipulation of the retrograde transport pathway by VPS35, providing new insight into the mechanism of PDCoV infection.
Identifiants
pubmed: 37815351
doi: 10.1128/jvi.00957-23
pmc: PMC10617406
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0095723Références
Antiviral Res. 2014 Sep;109:97-109
pubmed: 24995382
PLoS Pathog. 2022 Aug 25;18(8):e1010349
pubmed: 36007063
Front Cell Dev Biol. 2021 Mar 04;9:648024
pubmed: 33748141
Transbound Emerg Dis. 2017 Feb;64(1):3-10
pubmed: 27718337
Elife. 2023 Jan 25;12:
pubmed: 36695574
PLoS Pathog. 2016 Sep 20;12(9):e1005854
pubmed: 27649450
J Neurosci. 2012 Jan 25;32(4):1467-80
pubmed: 22279231
Vet Microbiol. 2016 Nov 30;196:98-106
pubmed: 27939164
Viruses. 2012 Nov 07;4(11):2902-23
pubmed: 23202509
Virology. 2021 Apr;556:1-8
pubmed: 33515858
J Gen Virol. 2013 Jul;94(Pt 7):1647-1657
pubmed: 23580427
Cell. 1991 Nov 1;67(3):449-51
pubmed: 1934055
Virology. 2016 Aug;495:10-7
pubmed: 27152478
Emerg Infect Dis. 2015 Dec;21(12):2254-5
pubmed: 26584185
J Virol. 2021 Oct 13;95(21):e0094421
pubmed: 34406863
Virol J. 2020 Aug 27;17(1):131
pubmed: 32854725
Sci Rep. 2023 Jun 8;13(1):9330
pubmed: 37291167
Science. 2009 Sep 4;325(5945):1217-20
pubmed: 19729648
Emerg Infect Dis. 2020 Feb;26(2):255-265
pubmed: 31961296
J Virol. 2021 Nov 23;95(24):e0111821
pubmed: 34549985
Transbound Emerg Dis. 2019 Jul;66(4):1436-1441
pubmed: 30941894
Nat Chem Biol. 2009 Mar;5(3):157-65
pubmed: 19182783
Nat Commun. 2021 Feb 11;12(1):961
pubmed: 33574281
Viruses. 2021 Jun 13;13(6):
pubmed: 34199223
J Cell Sci. 2012 Oct 15;125(Pt 20):4693-702
pubmed: 23148298
PLoS Pathog. 2014 Nov 13;10(10):e1004518
pubmed: 25393110
Transbound Emerg Dis. 2020 Mar;67(2):572-583
pubmed: 31541590
Virology. 2016 Dec;499:170-177
pubmed: 27661736
Arch Virol. 2021 Mar;166(3):935-941
pubmed: 33492525
Cell. 2006 Feb 24;124(4):729-40
pubmed: 16497584
mSphere. 2019 Jun 26;4(3):
pubmed: 31243080
Cell. 1991 Nov 1;67(3):601-16
pubmed: 1682055
J Adv Vet Anim Res. 2021 Jun 23;8(2):300-306
pubmed: 34395601
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
Adv Enzyme Regul. 2010;50(1):216-36
pubmed: 19900471
Virol Sin. 2022 Jun;37(3):321-330
pubmed: 35513271
Arch Virol. 2017 Apr;162(4):919-929
pubmed: 27942972
Cell. 2010 Apr 16;141(2):231-42
pubmed: 20403321
Emerg Infect Dis. 2014 Jul;20(7):1227-30
pubmed: 24964136
J Cell Biol. 2008 Nov 3;183(3):513-26
pubmed: 18981234
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7452-7
pubmed: 23569269
Viruses. 2021 Oct 04;13(10):
pubmed: 34696421
J Virol. 2021 Nov 23;95(24):e0134521
pubmed: 34586858
Viruses. 2019 Jun 21;11(6):
pubmed: 31234434
BMC Vet Res. 2022 Dec 22;18(1):444
pubmed: 36550483
Cell Mol Life Sci. 2016 Feb;73(4):869-81
pubmed: 26298293
Emerg Microbes Infect. 2020 Dec;9(1):20-31
pubmed: 31859605
Mol Biol Cell. 2000 Dec;11(12):4105-16
pubmed: 11102511
EBioMedicine. 2023 Mar;89:104451
pubmed: 36738481
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2208525120
pubmed: 36574644
Int J Mol Sci. 2018 Sep 04;19(9):
pubmed: 30181457
Cell. 2008 Dec 26;135(7):1175-87
pubmed: 19109890
FEBS Lett. 2020 Mar;594(5):823-840
pubmed: 31693752
Nature. 2021 Dec;600(7887):133-137
pubmed: 34789872
J Virol. 2015 Feb;89(3):1673-87
pubmed: 25410859
Vet Sci. 2020 Jun 22;7(2):
pubmed: 32580381
PLoS Pathog. 2015 Feb 18;11(2):e1004699
pubmed: 25693203
Diseases. 2016 Jul 25;4(3):
pubmed: 28933406
Emerg Infect Dis. 2015 Apr;21(4):650-4
pubmed: 25811229
J Gen Virol. 2017 Feb;98(2):173-178
pubmed: 27995863
Arch Virol. 2017 Aug;162(8):2357-2362
pubmed: 28374120
Protein Cell. 2014 Sep;5(9):655-7
pubmed: 25103897
Cold Spring Harb Perspect Biol. 2014 Feb 01;6(2):
pubmed: 24492709
Antiviral Res. 2006 Nov;72(2):78-88
pubmed: 16820226
Lancet Microbe. 2022 Nov;3(11):e808
pubmed: 35878623
J Virol. 2013 Apr;87(7):3862-70
pubmed: 23345514
J Cell Biol. 1998 Aug 10;142(3):665-81
pubmed: 9700157
PLoS Pathog. 2022 Sep 21;18(9):e1010834
pubmed: 36129908